Amedeo Smart

Free Medical Literature Service

 

Amedeo

Rheumatoid Arthritis
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. HAI BB, Anh TL, Thi Thu PN, Van HN, et al
    Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study.
    PLoS One. 2024;19:e0295048.
    >> Share

  2. MOMOSE T, Nakano M, Nakamura Y, Maeda T, et al
    Incidence and preventive treatment for deep vein thrombosis with our own preventive protocol in total hip and knee arthroplasty.
    PLoS One. 2024;19:e0293821.
    >> Share

  3. WU L, Wang Q, Gao QC, Shi GX, et al
    Potential mechanisms and drug prediction of Rheumatoid Arthritis and primary Sjogren's Syndrome: A public databases-based study.
    PLoS One. 2024;19:e0298447.
    >> Share

  4. LIU Z, Shao Y, Duan X
    Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298225.
    >> Share

  5. BERGMANS B, Jessurun N, van Lint J, Murk JL, et al
    Burden of non-serious infections during biological use for rheumatoid arthritis.
    PLoS One. 2024;19:e0296821.
    >> Share

  6. DE ARAUJO BMM, de Miranda BM, Kowaltschuk TC, Goncalves FM, et al
    Impact of chronic diseases on the periapical health of endodontically treated teeth: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297020.
    >> Share

  7. HUANG Z, Cui T, Yao J, Wu Y, et al
    Potential association of genetically predicted lipid and lipid-modifying drugs with rheumatoid arthritis: A Mendelian randomization study.
    PLoS One. 2024;19:e0298629.
    >> Share

  8. MORI S, Ueki Y, Hasegawa M, Nakamura K, et al
    Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study.
    PLoS One. 2024;19:e0298573.
    >> Share

  9. TENG M, Wang J, Su X, Tian Y, et al
    Causal associations between rheumatoid arthritis, cataract and glaucoma in European and East Asian populations: A bidirectional two-sample mendelian randomization study.
    PLoS One. 2024;19:e0299192.
    >> Share

  10. SHRESTHA DS, Manandhar S, Chalise BS, Rajbhandari SK, et al
    Symptoms 6 months following SARS-CoV-2 infection in Nepali women.
    PLoS One. 2024;19:e0299141.
    >> Share

  11. SAKASHITA E, Nagatani K, Endo H, Minota S, et al
    Biomarker combination predicting imminent relapse after discontinuation of biological drugs in patients with rheumatoid arthritis in remission.
    PLoS One. 2024;19:e0299450.
    >> Share

  12. DUDEK G, Sakowski S, Brzezinska O, Sarnik J, et al
    Machine learning-based prediction of rheumatoid arthritis with development of ACPA autoantibodies in the presence of non-HLA genes polymorphisms.
    PLoS One. 2024;19:e0300717.
    >> Share

  13. ZHANG Z, Chen Y, Fu X, Chen L, et al
    Identification of PPARG as key gene to link coronary atherosclerosis disease and rheumatoid arthritis via microarray data analysis.
    PLoS One. 2024;19:e0300022.
    >> Share

  14. CAI X, Jin Z, Zhang S, Liu J, et al
    Sjogren's syndrome and Parkinson's Disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298778.
    >> Share

  15. LI R, Yuan X, Ou Y
    Global burden of rheumatoid arthritis among adolescents and young adults aged 10-24 years: A trend analysis study from 1990 to 2019.
    PLoS One. 2024;19:e0302140.
    >> Share

    January 2023
  16. GALINDO-DONAIRE JR, Hernandez-Molina G, Fresan Orellana A, Contreras-Yanez I, et al
    The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis.
    PLoS One. 2023;18:e0280219.
    >> Share

  17. SONG YJ, Cho SK, Kim H, Kim HW, et al
    Factors associated with selection of targeted therapy in patients with rheumatoid arthritis.
    PLoS One. 2023;18:e0280234.
    >> Share

  18. YANG S, Min HK, Park JS, Na HS, et al
    A green-lipped mussel prevents rheumatoid arthritis via regulation of inflammatory response and osteoclastogenesis.
    PLoS One. 2023;18:e0280601.
    >> Share

  19. SANTO RCDE, Baker JF, Dos Santos LP, Silva JMS, et al
    Changes in physical function over time in rheumatoid arthritis patients: A cohort study.
    PLoS One. 2023;18:e0280846.
    >> Share

  20. CONIGLIARO P, D'Antonio A, D'Erme L, Lavinia Fonti G, et al
    Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy.
    PLoS One. 2023;18:e0281213.
    >> Share

  21. HA SJ, Park SJ, Lee B, Moon H, et al
    Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: A Korean nationwide cohort study.
    PLoS One. 2023;18:e0281067.
    >> Share

  22. IZUMI K, Suzuki K, Hashimoto M, Endoh T, et al
    Detecting hand joint ankylosis and subluxation in radiographic images using deep learning: A step in the development of an automatic radiographic scoring system for joint destruction.
    PLoS One. 2023;18:e0281088.
    >> Share

  23. NGUYEN THP, Fagerland MW, Hollan I, Whist JE, et al
    High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis.
    PLoS One. 2023;18:e0281155.
    >> Share

  24. NAKAMURA H, Tanaka T, Ji Y, Zheng C, et al
    Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjogren's disease.
    PLoS One. 2023;18:e0282227.
    >> Share

  25. AKASAKA D, Iguchi S, Kaneko R, Yoshiga Y, et al
    Novel Bruton's tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis.
    PLoS One. 2023;18:e0282117.
    >> Share

  26. TALMON M, Percio M, Obeng JA, Ruffinatti FA, et al
    Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.
    PLoS One. 2023;18:e0282564.
    >> Share

  27. CHI C, Solomon O, Shiboski C, Taylor KE, et al
    Identification of Sjogren's syndrome patient subgroups by clustering of labial salivary gland DNA methylation profiles.
    PLoS One. 2023;18:e0281891.
    >> Share

  28. LIN HL, Parkinson DH, Holman JC, Thompson WC, et al
    Modification of the structural stability of human serum albumin in rheumatoid arthritis.
    PLoS One. 2023;18:e0271008.
    >> Share

  29. TYAGI N, Mehla K, Gupta D
    Deciphering novel common gene signatures for rheumatoid arthritis and systemic lupus erythematosus by integrative analysis of transcriptomic profiles.
    PLoS One. 2023;18:e0281637.
    >> Share

  30. ZHAO X, Yang Y, Yue R, Su C, et al
    Potential causal association between leisure sedentary behaviors, physical activity and musculoskeletal health: A Mendelian randomization study.
    PLoS One. 2023;18:e0283014.
    >> Share

  31. CIAFFI J, Ruscitti P, Di Cola I, Pavlych V, et al
    Whole body insulin sensitivity is increased in systemic sclerosis.
    PLoS One. 2023;18:e0283283.
    >> Share

  32. GINEYTS E, Millet M, Borel O, Coutant F, et al
    Serum Col3-4: A new type III and IV collagen biochemical marker of synovial tissue turnover in patients with rheumatoid arthritis.
    PLoS One. 2023;18:e0282954.
    >> Share

  33. VASILEIADIS GK, Sayols S, Zhao SS, Fatima T, et al
    Adipokines and risk of rheumatoid arthritis: A two-sample multivariable Mendelian randomisation study.
    PLoS One. 2023;18:e0286981.
    >> Share

  34. ZHANG M, Yin J, Zhang X
    Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286191.
    >> Share

  35. KRISHNAMURTHY H, Yang Y, Song Q, Krishna K, et al
    Evaluation of renal markers in systemic autoimmune diseases.
    PLoS One. 2023;18:e0278441.
    >> Share

  36. WEMAN L, Salo H, Kuusalo L, Huhtakangas J, et al
    Initial presentation of early rheumatoid arthritis.
    PLoS One. 2023;18:e0287707.
    >> Share

  37. HUSSAIN MZ, Haris MS, Rizwan M, Ashraf NS, et al
    Deregulation of exosomal miRNAs in rheumatoid arthritis patients.
    PLoS One. 2023;18:e0289301.
    >> Share

  38. FAQUETTI ML, Vallejo-Yague E, Cordtz R, Dreyer L, et al
    JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register.
    PLoS One. 2023;18:e0288757.
    >> Share

  39. MESA LE, Lopez JG, Lopez Quiceno L, Barrios Arroyave F, et al
    Safety and efficacy of mesenchymal stem cells therapy in the treatment of rheumatoid arthritis disease: A systematic review and meta-analysis of clinical trials.
    PLoS One. 2023;18:e0284828.
    >> Share

  40. FELIX GOMEZ GG, Hugenberg ST, Zunt S, Patel JS, et al
    Characterizing clinical findings of Sjogren's Disease patients in community practices using matched electronic dental-health record data.
    PLoS One. 2023;18:e0289335.
    >> Share

  41. CHAPLIN H, Bosworth A, Simpson C, Wilkins K, et al
    Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process.
    PLoS One. 2023;18:e0289760.
    >> Share

  42. MUMTAZ T, Tahir A, Tariq MA, Iqbal MA, et al
    Comparative analysis of multiorgan toxicity induced by long term use of disease modifying anti-rheumatic drugs.
    PLoS One. 2023;18:e0290668.
    >> Share

  43. UMEMOTO A, Ito H, Azukizawa M, Murata K, et al
    How do symptoms of each joint contribute to global pain, disease activity and functional disability in rheumatoid arthritis?-A comprehensive association study using a large cohort.
    PLoS One. 2023;18:e0285227.
    >> Share

  44. YAGINUMA H, Saito Y, Sato T, Yamashita D, et al
    Clinical characteristics and outcomes of patients with chronic systemic inflammatory disease in acute myocardial infarction.
    PLoS One. 2023;18:e0289794.
    >> Share

  45. MCCREADY JL, McCarty K, Deary V, Collins TL, et al
    A qualitative exploration of internet forum discussions surrounding female sexual function for individuals with Sjogren's syndrome.
    PLoS One. 2023;18:e0291422.
    >> Share

  46. LOURINHO I, Sousa T, Jardim R, Pinto AC, et al
    Effects of low-level laser therapy in adults with rheumatoid arthritis: A systematic review and meta-analysis of controlled trials.
    PLoS One. 2023;18:e0291345.
    >> Share

  47. YAMAGUCHI S, Kimura S, Watanabe S, Mikami Y, et al
    Internet search analysis on the treatment of rheumatoid arthritis: What do people ask and read online?
    PLoS One. 2023;18:e0285869.
    >> Share

  48. ALI Y, Kausar M, Farooq M, Farooqi N, et al
    Association of IL-17F rs2397084 (E126G), rs11465553 (V155I) and rs763780 (H161R) variants with rheumatoid arthritis and their effects on the stability of protein.
    PLoS One. 2023;18:e0285874.
    >> Share

  49. BESSA EJC, Ribeiro FMC, Rodrigues RS, Henrique da Costa C, et al
    Association between clinical, serological, functional and radiological findings and ventilatory distribution heterogeneity in patients with rheumatoid arthritis.
    PLoS One. 2023;18:e0291659.
    >> Share

  50. ZENG HL, Qiu Q, Fu TX, Deng AP, et al
    Development and optimization of sustained release triptolide microspheres.
    PLoS One. 2023;18:e0292861.
    >> Share

  51. HUGHES-AUSTIN JM, Katz R, Majka DS, Criqui MH, et al
    Serum reactivity to citrullinated protein/peptide antigens and left ventricular structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA).
    PLoS One. 2023;18:e0291967.
    >> Share

  52. PORTES J, Santo RCE, Xavier RM, Brenol CV, et al
    Funcionality assessed by the core set of the international classification of functionality and health for rheumatoid arthritis: A cohort study.
    PLoS One. 2023;18:e0286342.
    >> Share

  53. MILADI S, Makhlouf Y, Boussaa H, Zakraoui L, et al
    Effect of bariatric and metabolic surgery on rheumatoid arthritis outcomes: A systematic review.
    PLoS One. 2023;18:e0294277.
    >> Share

  54. XU S, Zhang Q, Zhou J
    The mediting role of psychological resilience on the negative effect of pain in patients with rheumatoid arthritis: A cross-sectional study.
    PLoS One. 2023;18:e0295255.
    >> Share

  55. MUNIR A, Khan S, Khan S, Attaullah S, et al
    Frequency and association of Epstein-Barr Virus genotype in rheumatoid arthritis patients of Khyber Pakhtunkhwa, Pakistan.
    PLoS One. 2023;18:e0295124.
    >> Share

    January 2022
  56. YANAGISAWA S, Nagasaki K, Chea C, Ando T, et al
    Oral administration of bovine lactoferrin suppresses the progression of rheumatoid arthritis in an SKG mouse model.
    PLoS One. 2022;17:e0263254.
    >> Share

  57. LIU C, Fan F, Zhong L, Su J, et al
    Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology.
    PLoS One. 2022;17:e0262469.
    >> Share

  58. NGUYEN THP, Hokstad I, Fagerland MW, Mollnes TE, et al
    Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
    PLoS One. 2022;17:e0264628.
    >> Share

  59. HU J, Zhao L, Li N, Yang Y, et al
    Investigation of the active ingredients and pharmacological mechanisms of Porana sinensis Hemsl. Against rheumatoid arthritis using network pharmacology and experimental validation.
    PLoS One. 2022;17:e0264786.
    >> Share

  60. YASUDA T, Tahara K, Sawada T
    Detection of salivary citrullinated cytokeratin 13 in healthy individuals and patients with rheumatoid arthritis by proteomics analysis.
    PLoS One. 2022;17:e0265687.
    >> Share

  61. WHITE IR, Kleinstein SE, Praet C, Chamberlain C, et al
    A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
    PLoS One. 2022;17:e0261165.
    >> Share

  62. SHIRAISHI K, Chiba K, Watanabe K, Oki N, et al
    Analysis of bone erosions in rheumatoid arthritis using HR-pQCT: Development of a measurement algorithm and assessment of longitudinal changes.
    PLoS One. 2022;17:e0265833.
    >> Share

  63. NAM SH, Ahn SM, Oh JS, Hong S, et al
    Macrophage activation syndrome in rheumatic disease: Clinical characteristics and prognosis of 20 adult patients.
    PLoS One. 2022;17:e0267715.
    >> Share

  64. GENC D, Bulut O, Gunaydin B, Goksu M, et al
    Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjogren's syndrome murine model.
    PLoS One. 2022;17:e0266137.
    >> Share

  65. GHOURI M, Ismail M, Zaidi SA, Rehman S, et al
    Multi-locus SNP analyses of interleukin 1 receptor associated kinases 2 gene polymorphisms with the susceptibility to rheumatoid arthritis.
    PLoS One. 2022;17:e0268496.
    >> Share

  66. DESSIE G
    Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.
    PLoS One. 2022;17:e0269431.
    >> Share

  67. LI Z, Mu Y, Guo C, You X, et al
    Analysis of the saliva metabolic signature in patients with primary Sjogren's syndrome.
    PLoS One. 2022;17:e0269275.
    >> Share

  68. MORI S, Okada A, Koga T, Ueki Y, et al
    Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study.
    PLoS One. 2022;17:e0270391.
    >> Share

  69. MIKAMI S, Miura Y, Kondo S, Sakai K, et al
    Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis-associated interstitial lung disease mice.
    PLoS One. 2022;17:e0270056.
    >> Share

  70. GONI M, Basu N, Murray AD, Waiter GD, et al
    Brain predictors of fatigue in rheumatoid arthritis: A machine learning study.
    PLoS One. 2022;17:e0269952.
    >> Share

  71. WAKI D, Tamai H, Yokochi R, Kido T, et al
    Effects of anti-SSA antibodies on the response to methotrexate in rheumatoid arthritis: A retrospective multicenter observational study.
    PLoS One. 2022;17:e0271921.
    >> Share

  72. MOVAHEDI M, Cesta A, Li X, Bombardier C, et al
    Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort.
    PLoS One. 2022;17:e0274264.
    >> Share

  73. TEMMOKU J, Miyata M, Suzuki E, Sumichika Y, et al
    Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.
    PLoS One. 2022;17:e0274775.
    >> Share

  74. SANTOS IA, Donizeti Ribeiro de Oliveira R, Couto Luna Almeida S, Vargas-Santos AB, et al
    Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.
    PLoS One. 2022;17:e0273789.
    >> Share

  75. SCRIVO R, Molteni E, Castellani C, Altobelli A, et al
    Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
    PLoS One. 2022;17:e0275329.
    >> Share

  76. VALLEJO-YAGUE E, Pfund JN, Burkard T, Clair C, et al
    Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort.
    PLoS One. 2022;17:e0275026.
    >> Share

  77. REITER MP, Ward SH, Perry B, Mann A, et al
    Intra-articular injection of epigallocatechin (EGCG) crosslinks and alters biomechanical properties of articular cartilage, a study via nanoindentation.
    PLoS One. 2022;17:e0276626.
    >> Share

  78. JUNG N, Park S, Kong T, Park H, et al
    LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells.
    PLoS One. 2022;17:e0277218.
    >> Share

  79. TANAKA E, Inoue E, Shoji A, Nilsson J, et al
    Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.
    PLoS One. 2022;17:e0277566.
    >> Share

  80. LI Y, Li Z, Sun W, Wang M, et al
    Characteristics of gut microbiota in patients with primary Sjogren's syndrome in Northern China.
    PLoS One. 2022;17:e0277270.
    >> Share

  81. DISSANAYAKE K, Jayasinghe C, Wanigasekara P, Dissanayake J, et al
    Validity of clinical disease activity index (CDAI) to evaluate the disease activity of rheumatoid arthritis patients in Sri Lanka: A prospective follow up study based on newly diagnosed patients.
    PLoS One. 2022;17:e0278285.
    >> Share

  82. LOPEZ-OLIVO MA, Sharma G, Singh G, James J, et al
    A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis.
    PLoS One. 2022;17:e0279065.
    >> Share

  83. SCHMIDT NS, Voss A, Nilsson AC, Terslev L, et al
    Salivary gland ultrasound is associated with the presence of autoantibodies in patients with Sjogren's syndrome: A Danish single-centre study.
    PLoS One. 2022;17:e0265057.
    >> Share

  84. NARDINI C, Candelise L, Turrini M, Addimanda O, et al
    Semi-automated socio-anthropologic analysis of the medical discourse on rheumatoid arthritis: Potential impact on public health.
    PLoS One. 2022;17:e0279632.
    >> Share

    January 2021
  85. PAGLIA MDG, Silva MT, Lopes LC, Barberato-Filho S, et al
    Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
    PLoS One. 2021;16:e0248866.
    >> Share

  86. KUR-ZALEWSKA J, Kisiel B, Kania-Pudlo M, Tlustochowicz M, et al
    A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients.
    PLoS One. 2021;16:e0250339.
    >> Share

  87. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    Correction: (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0250451.
    >> Share

  88. LIN CT, Huang WN, Tsai WC, Chen JP, et al
    Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.
    PLoS One. 2021;16:e0250877.
    >> Share

  89. TATANGELO M, Tomlinson G, Paterson JM, Keystone E, et al
    Health care costs of rheumatoid arthritis: A longitudinal population study.
    PLoS One. 2021;16:e0251334.
    >> Share

  90. KATO M, Ikeda K, Sugiyama T, Tanaka S, et al
    Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis.
    PLoS One. 2021;16:e0252116.
    >> Share

  91. LEE DH, Sheen SH, Lee DG, Jang JW, et al
    Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
    PLoS One. 2021;16:e0251851.
    >> Share

  92. MATSUMOTO Y, Takahashi K, Sugioka Y, Inui K, et al
    Double-blinded randomized controlled trial to reveal the effects of Brazilian propolis intake on rheumatoid arthritis disease activity index; BeeDAI.
    PLoS One. 2021;16:e0252357.
    >> Share

  93. FRAENKEL L, Wei Z, Ramsey C, Wiedmeyer C, et al
    OPEX: Development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies.
    PLoS One. 2021;16:e0245598.
    >> Share

  94. NIK-AZIS NM, Mohd N, Mohd Fadzilah F, Mohamed Haflah NH, et al
    Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study.
    PLoS One. 2021;16:e0252859.
    >> Share

  95. REPAC J, Mandic M, Lunic T, Bozic B, et al
    Mining the capacity of human-associated microorganisms to trigger rheumatoid arthritis-A systematic immunoinformatics analysis of T cell epitopes.
    PLoS One. 2021;16:e0253918.
    >> Share

  96. KALWEIT M, Walker UA, Finckh A, Muller R, et al
    Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network.
    PLoS One. 2021;16:e0252289.
    >> Share

  97. DEYAB G, Reine TM, Vuong TT, Jenssen T, et al
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
    PLoS One. 2021;16:e0253247.
    >> Share

  98. TAKESHITA A, Nishida K, Yoshida A, Nasu Y, et al
    RANKL expression in chondrocytes and its promotion by lymphotoxin-alpha in the course of cartilage destruction during rheumatoid arthritis.
    PLoS One. 2021;16:e0254268.
    >> Share

  99. JAYARAM M, Wang C, Wang L, Chung KC, et al
    Validating the Michigan Hand Outcomes Questionnaire in patients with rheumatoid arthritis using Rasch analysis.
    PLoS One. 2021;16:e0254984.
    >> Share

  100. MOON SJ, Jhun J, Ryu J, Kwon JY, et al
    The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
    PLoS One. 2021;16:e0245986.
    >> Share

  101. RASKER JJ, Wolfe F, Klaver-Krol EG, Zwarts MJ, et al
    The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures.
    PLoS One. 2021;16:e0246051.
    >> Share

  102. MINAMINO H, Katsushima M, Hashimoto M, Fujita Y, et al
    Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database.
    PLoS One. 2021;16:e0255526.
    >> Share

  103. LIN PH, Yu SF, Chen JF, Chen YC, et al
    Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort study.
    PLoS One. 2021;16:e0255542.
    >> Share

  104. KUMAR SK, Arya S, Singh A, Misra R, et al
    Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    PLoS One. 2021;16:e0255639.
    >> Share

  105. TRIKHA R, Greig D, Sekimura T, Cevallos N, et al
    Active rheumatoid arthritis in a mouse model is not an independent risk factor for periprosthetic joint infection.
    PLoS One. 2021;16:e0250910.
    >> Share

  106. GONZALEZ-PONCE F, Gamez-Nava JI, Perez-Guerrero EE, Saldana-Cruz AM, et al
    Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
    PLoS One. 2021;16:e0255854.
    >> Share

  107. CHI C, Taylor KE, Quach H, Quach D, et al
    Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sjogren's syndrome.
    PLoS One. 2021;16:e0248429.
    >> Share

  108. KHALED SAA, Mahmoud HFF
    Platelet indices parameters in the new disease activity score of rheumatoid arthritis with ankle involvement: A comparative analytic study.
    PLoS One. 2021;16:e0257200.
    >> Share

  109. KARYDIS A, Sandal I, Luo J, Prislovsky A, et al
    Influence of the shared epitope on the elicitation of experimental autoimmune arthritis biomarkers.
    PLoS One. 2021;16:e0250177.
    >> Share

  110. DIAZ-GALLO LM, Brynedal B, Westerlind H, Sandberg R, et al
    Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations.
    PLoS One. 2021;16:e0250282.
    >> Share

  111. TURESSON WADELL A, Barebring L, Hulander E, Gjertsson I, et al
    Effects on health-related quality of life in the randomized, controlled crossover trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis).
    PLoS One. 2021;16:e0258716.
    >> Share

  112. NAKAE K, Masui S, Yonezawa A, Hashimoto M, et al
    Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data.
    PLoS One. 2021;16:e0258601.
    >> Share

  113. LIU W, Ma W, Liu H, Li C, et al
    Stroke risk in arthritis: A systematic review and meta-analysis of cohort studies.
    PLoS One. 2021;16:e0248564.
    >> Share

  114. SHIBATA K, Yoshimura A, Ikeuchi S, Ishii M, et al
    Effectiveness of drug safety measures for reducing the incidence of adverse drug reactions: Post-hoc analysis of data from all-case surveillance of iguratimod using generalized estimating equations.
    PLoS One. 2021;16:e0253513.
    >> Share

  115. DOS SANTOS LP, Santo RCDE, Ramis TR, Portes JKS, et al
    The effects of resistance training with blood flow restriction on muscle strength, muscle hypertrophy and functionality in patients with osteoarthritis and rheumatoid arthritis: A systematic review with meta-analysis.
    PLoS One. 2021;16:e0259574.
    >> Share

  116. MATSUMOTO H, Fujita Y, Asano T, Matsuoka N, et al
    Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
    PLoS One. 2021;16:e0260254.
    >> Share

  117. KAWAHITO Y, Takakubo Y, Morinobu A, Matsubara N, et al
    Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
    PLoS One. 2021;16:e0259389.
    >> Share

  118. GVOZDJAKOVA A, Sumbalova Z, Kucharska J, Szamosova M, et al
    Platelet mitochondrial respiration and coenzyme Q10 could be used as new diagnostic strategy for mitochondrial dysfunction in rheumatoid diseases.
    PLoS One. 2021;16:e0256135.
    >> Share

  119. SEMBLER-MOLLER ML, Belstrom D, Locht H, Pedersen AML, et al
    Combined serum anti-SSA/Ro and salivary TRIM29 reveals promising high diagnostic accuracy in patients with primary Sjogren's syndrome.
    PLoS One. 2021;16:e0258428.
    >> Share

  120. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    >> Share

  121. FUJITA Y, Yago T, Asano T, Matsumoto H, et al
    Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
    PLoS One. 2021;16:e0255493.
    >> Share

  122. NOH ASM, Chuan TD, Khir NAM, Zin AAM, et al
    Effects of different doses of complete Freund's adjuvant on nociceptive behaviour and inflammatory parameters in polyarthritic rat model mimicking rheumatoid arthritis.
    PLoS One. 2021;16:e0260423.
    >> Share

  123. O'BRIEN P, Conley B, Bunzli S, Bullen J, et al
    Staying moving, staying strong: Protocol for developing culturally appropriate information for Aboriginal people with osteoarthritis, rheumatoid arthritis, lupus and gout.
    PLoS One. 2021;16:e0261670.
    >> Share

  124. CHENG BR, Chen JQ, Zhang XW, Gao QY, et al
    Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0261239.
    >> Share

  125. RUDD PA, Lim EXY, Stapledon CJM, Krishnan R, et al
    Pentosan polysulfate sodium prevents functional decline in chikungunya infected mice by modulating growth factor signalling and lymphocyte activation.
    PLoS One. 2021;16:e0255125.
    >> Share

  126. MIN HK, Kim SH, Park Y, Lee KA, et al
    Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjogren's syndrome.
    PLoS One. 2021;16:e0259519.
    >> Share

  127. CUI D, Mathews P, Li G, VanCourt S, et al
    Outcomes of Sjogren's versus non-Sjogren's related dry eye in a longitudinal, tertiary clinic-based sample.
    PLoS One. 2021;16:e0261241.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016